Log in to save to my catalogue

The mutational signatures of poor treatment outcomes on the drug-susceptible Mycobacterium tuberculo...

The mutational signatures of poor treatment outcomes on the drug-susceptible Mycobacterium tuberculo...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_6b5166dfedee46d29f1dbe0759c9a7d9

The mutational signatures of poor treatment outcomes on the drug-susceptible Mycobacterium tuberculosis genome

About this item

Full title

The mutational signatures of poor treatment outcomes on the drug-susceptible Mycobacterium tuberculosis genome

Publisher

England: eLife Sciences Publications Ltd

Journal title

eLife, 2023-05, Vol.12

Language

English

Formats

Publication information

Publisher

England: eLife Sciences Publications Ltd

More information

Scope and Contents

Contents

Drug resistance is a known risk factor for poor tuberculosis (TB) treatment outcomes, but the contribution of other bacterial factors to poor outcomes in drug-susceptible TB is less well understood. Here, we generate a population-based dataset of drug-susceptible
Mycobacterium tuberculosis
(MTB) isolates from China to identify factors associa...

Alternative Titles

Full title

The mutational signatures of poor treatment outcomes on the drug-susceptible Mycobacterium tuberculosis genome

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_6b5166dfedee46d29f1dbe0759c9a7d9

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_6b5166dfedee46d29f1dbe0759c9a7d9

Other Identifiers

ISSN

2050-084X

E-ISSN

2050-084X

DOI

10.7554/eLife.84815

How to access this item